Defensive Medicine Common Among Surgeons, Radiologists

This article originally appeared here.
Share this content:
Defensive Medicine Common Among Surgeons, Radiologists
Defensive Medicine Common Among Surgeons, Radiologists

(HealthDay News) -- Defensive medicine is commonly practiced among surgeons and radiologists in Austria, according to a study published online Jan. 6 in the Journal of Evaluation in Clinical Practice.

Michael Osti, M.D., from the Academic Hospital Feldkirch in Austria, and Johannes Steyrer, Ph.D., from the Vienna University of Economics and Business, surveyed orthopedic and trauma surgeons as well as radiologists form public hospitals to quantify the practice of defensive medicine.

The researchers found that the prevalence of defensive medicine was 97.7 percent. More than one-quarter of all diagnostic examinations (28 percent) are ordered by orthopedic or trauma surgeons for defensive reasons (on average, 19.6 investigations per month for the average surgeon). Participants report receiving 1.4 liability claims per month. The majority of doctors (81 percent) request additional diagnostic procedures for defensive purposes when treating high-risk patients. In radiology, the time spent on defensive practice is 9.2 hours per month, and among orthopedic and trauma surgeons, defensive practice equals 17 and 18 percent of total working time, respectively.

"Our results indicate the urgent necessity for confrontation with and solution for the increasing effort of self-protection within the health care system," the authors write.

Abstract
Full Text (subscription or payment may be required)

Share this content:

is free, fast, and customized just for you!

Already a member?

Sign In Now »

Drug Lookup

Browse drugs by: BrandGenericDisease

Trending Activities

All Professions



Sign up for myCME e-newsletters


More in Home

Social, Communication Delays With False-Negative on M-CHAT

Social, Communication Delays With False-Negative on M-CHAT

Delays for those who pass M-CHAT screening at 18 months but are later diagnosed with ASD

FDA Approves Aimovig to Prevent Migraines

FDA Approves Aimovig to Prevent Migraines

Patients taking Aimovig reported one to two fewer monthly migraine days than those taking pacebo

Risk of Dementia Up for Older Adults With Lowest Wealth

Risk of Dementia Up for Older Adults With ...

Increased risk seen independent of education, index of multiple deprivation, health indicators

is free, fast, and customized just for you!

Already a member?

Sign In Now »